Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukaemia

被引：0

作者：

Perz, JB ^{[1
]}

Sanz, J ^{[1
]}

Ghorashian, S ^{[1
]}

Chaidos, A ^{[1
]}

Kaeda, J ^{[1
]}

Szydlo, RM ^{[1
]}

Marin, DC ^{[1
]}

Olavarria, E ^{[1
]}

Apperley, JF ^{[1
]}

机构：

[1] Hammersmith Hosp, London, England

来源：

BONE MARROW TRANSPLANTATION | 2006年 / 37卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S227 / S227

页数：1

共 50 条

[41] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia [J].

Olavarria, E ;

Ottmann, OG ;

Deininger, M ;

Clark, RE ;

Bandini, G ;

Byrne, J ;

Lipton, J ;

Vitek, A ;

Michallet, M ;

Siegert, W ;

Ullmann, A ;

Wassmann, B ;

Niederwieser, D ;

Fischer, T .

LEUKEMIA, 2003, 17 (09) :1707-1712

[42] Current role of stem cell transplantation in chronic myeloid leukaemia [J].

Gratwohl, Alois ;

Heim, Dominik .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (03) :431-443

[43] First successful allogeneic hematopoietic stem cell transplantation in children with chronic myeloid leukemia, preceded by imatinib prior transplantation [J].

Wu, Kang-Hsi ;

Weng, Te-Fu ;

Chen, Ming-Chieh ;

Peng, Ching-Tien .

BLOOD, 2007, 110 (11) :213B-213B

[44] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN CHRONIC MYELOID LEUKAEMIA (CML): LONG TERM RESULTS [J].

Benakli, M. ;

Nacer, R. Ahmed ;

Talbi, A. ;

Mehdid, F. ;

Belhadj, R. ;

Baazizi, M. ;

Rahmoune, N. ;

Harieche, F. ;

Zerhouni, F. ;

Hamladji, R. M. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 :442-442

[45] Allogeneic stem cell transplantation in patients with chronic myeloid leukaemia: application of the EBMT risk scoring system [J].

Novella, E ;

Madeo, D ;

Raimondi, R ;

Cappellari, A ;

Guercini, N ;

Montaldi, AM ;

Roberti, S ;

Rodeghiero, F .

BONE MARROW TRANSPLANTATION, 2005, 35 :S235-S235

[46] Allogeneic bone marrow transplantation versus imatinib mesilate for patients with chronic myeloid leukaemia in first chronic phase [J].

Bittencourt, H. ;

Funke, V. ;

Fogliatto, L. ;

Magalhaes, S. ;

Setubal, D. ;

Paz, A. ;

Macedo, A. ;

Ruiz, J. ;

Azambuja, A. ;

Silla, L. ;

Clementino, N. ;

Pasquini, R. .

BONE MARROW TRANSPLANTATION, 2008, 41 :S305-S305

[47] Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukaemia [J].

Medinger, M. ;

Zeiter, D. ;

Heim, D. ;

Kleber, M. ;

Halter, J. ;

Gerull, S. ;

Passweg, J. ;

Nigro, N. .

BONE MARROW TRANSPLANTATION, 2017, 52 :S292-S292

[48] Development of donor cell derived acute myeloid leukaemia after stem cell transplantation for chronic myeloid leukaemia [J].

Pieroni, F ;

Oliveira, FM ;

Moraes, D ;

Straccieri, ABPL ;

Rodrigues, MC ;

Panepucci, RA ;

Voltarelli, JC ;

Simoes, BP ;

Falcao, RP .

BONE MARROW TRANSPLANTATION, 2006, 37 :S219-S220

[49] Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute myeloid leukaemia [J].

Min, W. S. ;

Cho, B. S. ;

Kim, H. J. ;

Kim, S. Y. ;

Eom, K. S. ;

Lee, J. W. ;

Kim, C. C. .

BONE MARROW TRANSPLANTATION, 2007, 39 :S59-S59

[50] Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia [J].

Radich, JP ;

Olavarria, E ;

Apperley, JF .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (03) :685-+

← 1 2 3 4 5 →